Please login to the form below
Translate Bio
This page shows the latest Translate Bio news and features for those working in and with pharma, biotech and healthcare.
Sanofi to invest €400m annually in mRNA vaccines facility
Sanofi added that the dedicated centre will also enable the acceleration of the mRNA vaccines portfolio developed as part of its partnership with US biotech company Translate Bio. ... Translate Bio and Sanofi signed an initial collaboration agreement in
Latest news
-
Sanofi and Translate Bio launch phase 1/2 trial of mRNA-based COVID-19 vaccine
Vaccine candidate induced high antibody levels in preclinical studies. Sanofi and Translate Bio have announced the launch of a phase 1/2 trial evaluating their mRNA-based COVID-19 vaccine candidate ... Sanofi and Translate will investigate three
-
Sanofi will provide manufacturing support for Pfizer/BioNTech’s COVID-19 vaccine
Meanwhile, a phase 1 trial of Sanofi’s other investigational vaccine candidate, currently being developed with Translate Bio, is expected to launch in Q1.
-
Sanofi’s quadrivalent flu vaccine Supemtek scores EU approval
In addition to the GSK partnership, Sanofi also signed an agreement with Translate Bio to develop an mRNA-based COVID-19 vaccine.
-
Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study
Preclinical data for mRNA-based vaccine supports clinical development. Sanofi and Translate Bio’s mRNA-based COVID-19 vaccine induced high antibody levels in preclinical studies, leading to the production of ... According to Sanofi and Translate Bio,
-
Translate Bio, Sanofi's COVID-19 vaccine proves promising in animal studies
Vaccine was able to induce neutralising antibodies and T-cell responses. Translate Bio has announced that its Sanofi-partnered experimental COVID-19 vaccine induced immune responses in animal studies, as they ... We are excited by the novel technology
Sanofi and Translate Bio launch phase 1/2 trial of mRNA-based COVID-19 vaccine
Sanofi will provide manufacturing support for Pfizer/BioNTech’s COVID-19 vaccine
Sanofi’s quadrivalent flu vaccine Supemtek scores EU approval
More from news
Approximately 4 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
COVID-19: the race to find a vaccine
BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.
-
Developing a COVID-19 vaccine
The second agreement, with Translate Bio, will focus on developing an mRNA vaccine for COVID-19. ... Translate has already begun to produce multiple mRNA constructs and will use its platform to discover, design and manufacture a number of coronavirus
COVID-19: the race to find a vaccine
Developing a COVID-19 vaccine
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Ann Barbier joins Translate Bio as its chief medical officer
US-based biotech Translate Bio has appointed Ann Barbier as its new chief medical officer. ... She said: “With near-term clinical programmes in cystic fibrosis and OTC deficiency, Translate Bio is approaching a critical and exciting time.
-
US biotech Translate Bio appoints Daniella Beckman
She joins the board of directors. Translate Bio has appointed Daniella Beckman to its board of directors and she will also serve at the US biotech as chairperson of its ... Ronald Renaud, chief executive officer, Translate Bio, said: “Daniella joins
Ann Barbier joins Translate Bio as its chief medical officer
US biotech Translate Bio appoints Daniella Beckman
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
-
Digital project manager
-
Competitive
-
Digital account director
-
Competitive
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital strategist
-
Competitive
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- GSK reveals plans for £400m R&D facility expansion in England
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Merck & Co's cancer drug Keytruda gaining traction in US
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
